The contribution of NF-κB to cardiovascular disease, like atherosclerosis, is most easily understood in the context of chronic inflammation, wherein proinflammatory cytokines drive the activation of NF-κB that in turn drives target gene expression [24]. This evidence concerns the gene NFKB1 and cardiovascular disorder.